Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Michael Rhodes, Michael Becich

Premium

Michael Rhodes has left his position at Life Technologies to join NanoString Technologies as director of collaboration and applications development, where he will focus on digital gene expression.

Rhodes held various positions at Life Tech, including most recently senior manager of the company's sequencing portfolio. He joined Life Tech predecessor Applied Biosystems in 1999 in the genetic analysis division.

In his new position, he will report to Joe Beechem, who also recently joined NanoString from Life Tech, where he was most recently vice president, head of advanced sequencing, and head of global sequencing chemistry, biochemistry, and biophysics.


Empire Genomics has appointed Michael Becich to serve on its scientific advisory board. Becich is a professor and founding chair of the department of biomedical informatics at the University of Pittsburgh School of Medicine.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.